Meet the Unstoppable Artificial Intelligence (AI) Stock Obliterating Every Member of the "Magnificent Seven" in 2026

DigitalOcean said AI product ARR reached $120 million in Q4, up 150% year over year, while 2025 revenue grew 15% to $901 million. Management expects overall revenue growth to accelerate to 21% in 2026 and 30% in 2027 as AI demand drives expansion of GPU-backed data centers. The article argues the stock still looks attractive at 11.1x sales versus a 6.9x forward P/S on 2027 revenue.

Analysis

The market is starting to price a second-order beneficiary of the AI capex cycle: not the hyperscalers themselves, but the “long tail” infrastructure layer that wins when customers want smaller minimum commitments, faster onboarding, and simpler cost control. DOCN’s edge is less about raw compute and more about packaging scarce GPU capacity into bite-sized demand that the big three cloud platforms are structurally less incentivized to serve. That creates a favorable revenue mix shift: once a customer starts on a small AI workload, expansion can compound quickly if the workflow becomes embedded.

The key risk is that this is a supply-constrained story masquerading as a demand story. If new GPU capacity comes online faster than expected, DOCN’s pricing premium and utilization leverage could normalize quickly, and the current rerating would compress before revenue inflects enough to justify it. The next 2-3 quarters matter more than the next 2-3 years: if management’s acceleration narrative is real, bookings and high-end customer spend should lead reported revenue by at least one quarter.

For AMZN, MSFT, and GOOGL, the read-through is subtle: they are not losing the AI cloud war overall, but they may be ceding the SMB and startup edge to a specialist that can monetize fragmented demand more efficiently. That is mildly negative for incremental share capture but positive for the ecosystem because it broadens AI adoption beyond enterprise budgets; it also supports GPU demand for NVDA and AMD by opening a new customer segment that is volume-sensitive rather than margin-sensitive. The contrarian view is that DOCN may actually be under-earning its option value: if small AI workloads proliferate, its valuation should behave less like a mature cloud name and more like a capacity-constrained platform with operating leverage.

Key Decisions for Investors

• Go long DOCN on pullbacks over the next 2-6 weeks; target a 12-month hold with upside tied to 2026-2027 revenue re-acceleration. Risk/reward is attractive if the stock is still valued on current growth rather than forward growth, but trim aggressively if utilization metrics stop improving.
• Pair trade: long DOCN / short a basket of AMZN, MSFT, GOOGL for 3-6 months. Thesis: incremental SMB AI share accrues to the specialist, while hyperscalers remain optimized for larger enterprise deals; hedge ratios should favor equal-dollar exposure because DOCN beta is higher.
• Buy NVDA and AMD on weakness as a second-order beneficiary trade over the next 1-2 quarters. Even if DOCN’s margin story compresses, the GPU supply chain wins from broader deployment of small AI workloads; use DOCN-related strength as a timing signal for semis entry.
• Consider DOCN call spreads 6-9 months out rather than outright equity if implied volatility remains elevated. This preserves upside to a rerating while limiting downside if GPU supply expansion eases pricing power sooner than expected.
• Set a catalyst stop: if the next earnings update does not show continued expansion in higher-spend customer cohorts, reduce exposure by 25-50%. The market is paying for acceleration, not just participation in AI.